Search
01/03/2025
INITIATING GLUCOSE MONITORING IN PERSONS WITH TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROL TRIAL COMPARING FSL2 VS. CAPILLARY BLOOD GLUCOSE IN TERMS OF TREATMENT SATISFACTION
Mangas, N, Abraldes, N, Martínez, MJ, Figueroa, D, Ramos, M, López, A, Martínez, C, Pujol, I, Mauricio, D, Corcoy, R. INITIATING GLUCOSE MONITORING IN PERSONS WITH TYPE 2 DIABETES MELLITUS. A RANDOMIZED CONTROL TRIAL COMPARING FSL2 VS. CAPILLARY BLOOD GLUCOSE IN TERMS OF TREATMENT SATISFACTION. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03
Paldánius, PM, Cos, X, Lazaro-Pancheco, D, Salter, J, Mauricio, D. NON-INVASIVE NEAR-INFRARED SYSTEM FOR SCREENING FOR DIABETES: THE RESULTS FROM ANODE03. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS
Paldánius, PM, Salter, J, Hernandez, ME, Tipo, B, Franch, J, Cos, X, Mauricio, D. ASSESSING IMPLEMENTATION OF NOVEL DIABETES SCREENING METHODS ACROSS DIFFERENT CARE DELIVERY SETTINGS. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
BENEFIT:RISK ASSESSMENT OF A NOVEL NON-INVASIVE SCREENING TOOL: INSIGHTS FROM THE ANODE CLINICAL PROGRAMME
Paldánius, PM, Salter, J, Choudhary, P, Cos, X, Mauricio, D. BENEFIT:RISK ASSESSMENT OF A NOVEL NON-INVASIVE SCREENING TOOL: INSIGHTS FROM THE ANODE CLINICAL PROGRAMME. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/03/2025
USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY
Chico, A, Ampudia-Blasco, FJ, Daín, A, Scheibner, K, Dagenbach, N, Grifoll-Romero, L, Barmaymon, D, Vogt, G, Best, J, Etter, T. USER SATISFACTION AND GLYCEMIC OUTCOMES IN PWT1D USING AN INNOVATIVE MICROPUMP: INTERIM ANALYSIS OF AN OBSERVATIONAL STUDY. Diabetes Technology & Therapeutics. 2025; 27DOI:. PMID:. IF:6.300(Q1/2D).
01/02/2022
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas
Tritos NA, Fazeli PK, McCormack A, Mallea-Gil SM, Pineyro MM, Christ-Crain M, Frara S, Labadzhyan A, Ioachimescu AG, Shimon I, Takahashi Y, Gurnell M, Fleseriu M, Valassi E., Wierman, Margaret E.. Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas. Pituitary. 2022; 25(1)DOI:10.1007/s11102-021-01170-3. PMID:34283370. IF:3.800(Q2/5D).
01/09/2021
Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.
Calderon-Mediavilla M, Vila-Badia R, Dolz M, Butjosa A, Barajas A, Del Cacho N, Sánchez B, Pardo M, Baños I, Usall J, Ochoa S, Santos, A, Nunez, C, Soler, A.. Depressive symptoms and their relationship with negative and other psychotic symptoms in early onset psychosis.. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2021; 30(9)DOI:10.1007/s00787-020-01618-0. PMID:32865655. IF:5.349(Q1/1D).
01/02/2026
Oxytocin levels do not change around a meal and correlate with reward-driven caloric consumption in adults with obesity
Wronski, M, Boutin, R, Sailer, CO, Galbiati, F, Aulinas, A, Muhammed, M, Eddy, KT, Thomas, JJ, Kerem, L, Carter, CS, Nazarloo, S, Davis, JM, Blevins, JE, Holman, K, Gydus, J, Smith, SE, Asanza, E, Plessow, F, Lawson, EA. Oxytocin levels do not change around a meal and correlate with reward-driven caloric consumption in adults with obesity. DIABETES OBESITY & METABOLISM. 2026; 28(2)DOI:10.1111/dom.70340. PMID:41392857. IF:5.700(Q1/2D).
08/01/2026
Assessing the Value of Data-Driven Frameworks for Personalized Medicine in Pituitary Tumours: A Critical Overview
Gil, J, de Pedro-Campos, P, Carrato, C, Jardí-Yanes, P, Marques-Pamies, M, Rodríguez-Lloveras, H, Rueda-Pujol, A, Marcos-Ruiz, J, Martinez-Saez, E, Alvarez, CV, Bernabéu, I, Delgado, E, Lamas, C, Picó, A, Webb, SM, Menéndez, E, Martínez-Hernández, R, Sampedro, M, Aulinas, A, Biagetti, B, Marazuela, M, Valassi, E, Jordà, M, Puig-Domingo, M. Assessing the Value of Data-Driven Frameworks for Personalized Medicine in Pituitary Tumours: A Critical Overview. Machine Learning And Knowledge Extraction. 2026; 8(1)DOI:10.3390/make8010016. PMID:. IF:(Q/D).
01/01/2026
Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans
Galbiati, F, Plessow, F, Plummer, L, Campbell, MB, Nazarloo, S, Carter, CS, Davis, JM, Miller, KK, Carroll, RS, Kaiser, UB, Seminara, SB, Aulinas, A, Lawson, EA. Intravenous kisspeptin 112-121 bolus does not acutely impact circulating vasopressin in humans. JOURNAL OF NEUROENDOCRINOLOGY. 2026; 38(1)DOI:10.1111/jne.70114. PMID:41273106. IF:4.100(Q1/3D).
01/11/2025
Consensus on acromegaly therapeutic outcomes: an update
Melmed, S, di Filippo, L, Fleseriu, M, Mercado, M, Karavitaki, N, Gurnell, M, Salvatori, R, Tsagarakis, S, Losa, M, Maffei, P, Pereira, AM, Geer, EB, Katznelson, L, van der Lely, AJ, Bollerslev, J, Esposito, D, Webb, SM, Zatelli, MC, Valassi, E, Neggers, S, Chanson, P, Ho, KKY, Ioachimescu, AG, Biller, BMK, Samson, SL, Kaiser, UB, Schilbach, K, Luque, RM, Casanueva, FF, Shimon, I, Boguszewski, CL, Biermasz, N, Colao, A, Pirchio, R, Lamberts, SWJ, Kadioglu, P, Buchfelder, M, Frara, S, Chiloiro, S, Petersenn, S, Gadelha, MR, Puig-Domingo, M, Luger, A, Brue, T, Beckers, A, Ferone, D, Clemmons, DR, Greenman, Y, Marazuela, M, Mortini, P, Strasburger, CJ, Giustina, A. Consensus on acromegaly therapeutic outcomes: an update. Nature Reviews Endocrinology. 2025; 21(11)DOI:10.1038/s41574-025-01148-2. PMID:40804505. IF:40.000(Q1/1D).
29/05/2025
Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly
Martel-Duguech, L, Bascuñana, H, Cuartero, J, Webb, SM, Valassi, E. Muscle dysfunction is associated with poor quality of life in long-term controlled patients with acromegaly. Pituitary. 2025; 28(3)DOI:10.1007/s11102-025-01539-8. PMID:40442526. IF:3.400(Q2/4D).
01/01/2024
Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.
García MJ, Rivero M, Fernández-Clotet A, de Francisco R, Sicilia B, Mesonero F, de Castro ML, Casanova MJ, Bertoletti F, García-Alonso FJ, López-García A, Vicente R, Calvet X, Barreiro-de Acosta M, Ferrer Rosique J, Varela Trastoy P, Nuñez A, Ricart E, Riestra S, Arias García L, Rodríguez M, Arranz L, Pajares R, Mena R, Calafat M, Camo P, Bermejo F, Ponferrada Á, Madrigal RE, Llaó J, Sesé E, Sánchez E, Pineda Mariño JR, González Muñoza C, Carbajo López AY, Julián AB, Villoria Ferrer A, Baston-Rey I, Jara L, Almela P, Codesido L, de la Maza S, Leal C, Caballol B, Pérez-Martínez I, Vinuesa Campo R, Crespo J, Domènech E, Chaparro M, Gisbert JP. Comparative Study Of The Effectiveness Of Vedolizumab Versus Ustekinumab After Anti-Tnf Failure In Crohn's Disease (Versus-Cd): Data From Eneida Registry.. Journal of Crohns & Colitis. 2024; 18(1)DOI:10.1093/ecco-jcc/jjad124. PMID:37522878. IF:8.700(Q1/1D).
01/12/2023
Management of small subepithelial tumors by endoscopic banding without resection and single-incision needle-knife-assisted biopsy sampling: a prospective multicenter study.
Bas-Cutrina F, Loras C, Pardo A, Ballester-Clau R, Huertas C, Guarner-Argente C, Colan-Hernandez J, Consiglieri CF, Andujar X, Vilanova-Serra M, González-Huix F, Pardo-Grau L, Maisterra S, Ruiz-Ramírez P, Garcia-Sumalla A, Tebé C, Videla S, Gornals JB. Management of small subepithelial tumors by endoscopic banding without resection and single-incision needle-knife-assisted biopsy sampling: a prospective multicenter study.. GASTROINTESTINAL ENDOSCOPY. 2023; 98(6)DOI:10.1016/j.gie.2023.05.057. PMID:37263361. IF:6.700(Q1/2D).
01/10/2023
Endoscopic Vacuum Therapy for Upper Gastrointestinal Leaks and Perforations: Analysis From a Multicenter Spanish Registry.
Momblan D, Gimeno Garcia AZ, Busquets D, Juzgado D, García Lledó J, Ferrero E, Tejedor-Tejada J, Junquera F, Díaz-Tasende J, Moris M, Rodriguez de Santiago E, Gornals J, Garrido C, Gonzalez-Vazquez S, Guarner-Argente C, Repiso A, Esteban JM, Loras C, Seoane A, Fernández-Simon A, Guevara HC, Ibarzabal A, Morales X, Curell A, Cardenas A, Ríos J, de Lacy AM, Sendino O. Endoscopic Vacuum Therapy for Upper Gastrointestinal Leaks and Perforations: Analysis From a Multicenter Spanish Registry.. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023; 118(10)DOI:10.14309/ajg.0000000000002475. PMID:37606066. IF:8.500(Q1/1D).
01/02/2026
Predictors of early immunosuppression at ulcerative colitis onset in the biological era
Piñero, G, Castillo, E, González-Muñoza, C, Calm, A, Pujol, C, Gordillo, J, Calafat, M, Bertoletti, F, Garcia-Planella, E, Mañosa, M, Domènech, E. Predictors of early immunosuppression at ulcerative colitis onset in the biological era. Gastroenterologia y Hepatologia. 2026; 49(2)DOI:10.1016/j.gastrohep.2025.502533. PMID:40680924. IF:1.900(Q3/7D).
01/01/2026
Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males
Teller, M, Giordano, A, González-Munoza, C, Gordillo, J, Bertoletti, F, Sánchez-Reus, F, Garcia-Planella, E. Clinical, endoscopic and histological characteristics of Chlamydia trachomatis proctitis in males. Gastroenterologia y Hepatologia. 2026; 49(1)DOI:10.1016/j.gastrohep.2025.502558. PMID:40930415. IF:1.900(Q3/7D).
01/01/2026
Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU
Ramos, CR, Sard, MC, Carballo-Folgoso, L, Ruiz-Rodríguez, J, Moya, MIC, Teller, M, Clotet, AF, Cortés, IL, San Martín, LZ, Moreno, CO, Rivas, C, Cuellar, MA, Elorza, A, Gisbert, J, Martinez, MR, Poceiro, JC, Brunet, E, Caravaca, C, Rey, IB, Piñero, GS, Diaz, AP, Orenga, C, Carrilloramos, MJ, Montero, MG, Sandoval, CT, Velázquez, LM, Olmedo-Martín, R, Catalá, AC, Alonso,, Molina, IGDL, Molina, F, Salmón, P, Giordano, A, Moranta, FR, Zabana, Y, Planella, EG. Impact of Multiple Sclerosis on the course of Inflammatory Bowel Disease: The MULTIPLEII case-control study from the Young Group of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.1197. PMID:. IF:8.700(Q1/1D).
01/01/2026
Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU
Casanova, MJ, Garcia, RMD, Ramos, CL, Camba, AH, Gargayo-Puyuelo, C, Senosiain, BC, Gismero, FM, Pagola, L, Cruañas, AA, Giordano, A, Diaz, AP, Velázquez, LM, Robledo-Andrés, P, Regueiro, C, Gonzalez, MS, Jara, RA, Santos, DC, Glaría, EB, Marquès-Camí, M, Trastoy, PV, Acosta, MBD, de la Osa, DR, Luque, RS, Teller, M, De Célix, CR, Almela, P, Font-Ordeig, G, Bujanda, L, Orenga-Sánchez, C, Oliveras-Font, B, Alvarez, PGI, Sánchez, RM, Guillena, PGD, Arce, NM, Martinez, IP, Alonso, FJG, Ramos, CR, Moral, ED, Chaparro, M, Gisbert, J. Prevalence, clinical characterisation and therapeutic outcomes of non-fistulising perianal lesions in Crohn's disease (ULCERS-CD): Results from the ENEIDA registry of GETECCU. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.960. PMID:. IF:8.700(Q1/1D).
01/01/2026
Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA
De Célix, CR, Granja, A, Iborra, M, Alonso, FJG, Vela, M, de Castro, L, García-Sola, C, Barrero, S, Trastoy, PV, Andrés, PR, Riestra, S, Diaz, AP, Santos, DC, Camps, B, Gisbert, J, García, MJ, Palomares, MTDL, Lozano, OM, de la Cruz, DR, López, E, Pascual, CM, Izquierdo, S, Flores, EI, Iglesias, RF, Argüelles-Arias, F, Martin, D, Ramírez, MAR, Villaamil, PV, Martinez, AMT, Ramos, CR, Velázquez, LM, Ciria, MM, Brunet, E, Zabana, Y, Villarroya, RP, Altadill, A, Moral, ED, Mateu, PN, Acosta, MBD, San Jose, FB. Comparative study on the effectiveness, durability, and safety of upadacitinib versus risankizumab after anti-TNF failure in Crohn's Disease: The U-PARIS study of ENEIDA. Journal of Crohns & Colitis. 2026; 20DOI:10.1093/ecco-jcc/jjaf231.069. PMID:. IF:8.700(Q1/1D).